Guideline | Drug Name |
---|---|
Venxxiva (tiopronin delayed-release) | Venxxiva (tiopronin delayed-release) |
Veopoz (pozelimab-bbfg) | Veopoz (pozelimab-bbfg) |
Veozah (fezolinetant) | Veozah (fezolinetant) |
Verkazia (cyclosporine ophthalmic emulsion 0.1%) - PA, NF | Verkazia (cyclosporine ophthalmic emulsion 0.1%) |
Verquvo (vericiguat) | Verquvo (vericiguat) |
Verzenio (abemaciclib) | Verzenio (abemaciclib) |
Vevye (cyclosporine ophthalmic solution 0.1%) | Vevye (cyclosporine ophthalmic solution 0.1%) |
Viibryd (vilazodone) | Viibryd (vilazodone) |
Vijoice (alpelisib) - PA, NF | Vijoice (alpelisib) |
Viltepso (viltolarsen) - PA, NF | Viltepso (viltolarsen) |
Vimizim (elosulfase alfa) | Vimizim (elosulfase alfa) |
Vimovo (naproxen/esomeprazole magnesium) | Vimovo (naproxen/esomeprazole magnesium) |
Vitrakvi (larotrectinib) | Vitrakvi (larotrectinib) |
Vivjoa (oteseconazole) | Vivjoa (oteseconazole) |
Vizimpro (dacomitinib) | Vizimpro (dacomitinib) |
Vonjo (pacritinib) | Vonjo (pacritinib) |
Vonoprazan Containing Agents - PA, NF | Voquezna (vonoprazan) |
Voranigo (Vorasidenib) | Voranigo (Vorasidenib) |
Vosevi (sofosbuvir/velpatasvir/voxilaprevir) | Vosevi (sofosbuvir/velpatasvir/voxilaprevir) |
Votrient (pazopanib) | Votrient (pazopanib) |